197 related articles for article (PubMed ID: 29127538)
1. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
Kantor O; Ajmani G; Wang CH; Datta A; Yao K
Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
[TBL] [Abstract][Full Text] [Related]
2. National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
Puig CA; Hoskin TL; Day CN; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 May; 24(5):1242-1250. PubMed ID: 28000076
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Li X; Yan C; Xiao J; Xu X; Li Y; Wen X; Wei H
Clin Breast Cancer; 2021 Oct; 21(5):e611-e617. PubMed ID: 34001440
[TBL] [Abstract][Full Text] [Related]
4. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
[TBL] [Abstract][Full Text] [Related]
5. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
Wapnir IL; Kurian AW; Lichtensztajn DY; Clarke CA; Gomez SL
Ann Surg; 2017 Aug; 266(2):353-360. PubMed ID: 27611617
[TBL] [Abstract][Full Text] [Related]
6. Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
Spronk PER; Volders JH; van den Tol P; Smorenburg CH; Vrancken Peeters MTFD
Eur J Surg Oncol; 2019 Feb; 45(2):110-117. PubMed ID: 30348601
[TBL] [Abstract][Full Text] [Related]
7. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.
Fancellu A; Sanna V; Cottu P; Feo CF; Scanu AM; Farina G; Bulla A; Spanu A; Paliogiannis P; Porcu A
Breast; 2018 Jun; 39():1-7. PubMed ID: 29454174
[TBL] [Abstract][Full Text] [Related]
8. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
Chen H; Zhang P; Zhang M; Wang M; Bai F; Wu K
J Surg Res; 2019 Jul; 239():224-232. PubMed ID: 30856515
[TBL] [Abstract][Full Text] [Related]
9. Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
Liu D; Chang L; Hao Q; Ren X; Liu P; Liu X; Wei Y; Wang M; Wu H; Kang H; Lin S
J Cancer Res Clin Oncol; 2024 May; 150(5):285. PubMed ID: 38814494
[TBL] [Abstract][Full Text] [Related]
10. Nationwide trends in mastectomy for early-stage breast cancer.
Kummerow KL; Du L; Penson DF; Shyr Y; Hooks MA
JAMA Surg; 2015 Jan; 150(1):9-16. PubMed ID: 25408966
[TBL] [Abstract][Full Text] [Related]
11. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
[TBL] [Abstract][Full Text] [Related]
12. Comparison of breast-conserving therapy vs mastectomy in women under age 40: National trends and potential survival implications.
Lazow SP; Riba L; Alapati A; James TA
Breast J; 2019 Jul; 25(4):578-584. PubMed ID: 31090168
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Care in the Administration of Neo-adjuvant Chemotherapy for Breast Cancer. A Population-Based Study.
Vugts G; Maaskant-Braat AJ; Nieuwenhuijzen GA; Roumen RM; Luiten EJ; Voogd AC
Breast J; 2016 May; 22(3):316-21. PubMed ID: 26945566
[TBL] [Abstract][Full Text] [Related]
14. Combination of breast imaging parameters obtained from
Grapin M; Coutant C; Riedinger JM; Ladoire S; Brunotte F; Cochet A; Humbert O
Eur J Radiol; 2019 Apr; 113():81-88. PubMed ID: 30927964
[TBL] [Abstract][Full Text] [Related]
15. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Shin HC; Han W; Moon HG; Im SA; Moon WK; Park IA; Park SJ; Noh DY
Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119
[TBL] [Abstract][Full Text] [Related]
16. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.
Simons JM; Jacobs JG; Roijers JP; Beek MA; Boonman-de Winter LJM; Rijken AM; Gobardhan PD; Wijsman JH; Tetteroo E; Heijns JB; Yick CY; Luiten EJT
Breast Cancer Res Treat; 2021 Jan; 185(2):441-451. PubMed ID: 33073303
[TBL] [Abstract][Full Text] [Related]
17. Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10-year (2006-2015) retrospective hospitalization summary report-based study.
Bao X; Sun K; Tian X; Yin Q; Jin M; Yu N; Jiang H; Zhang J; Hu Y
Thorac Cancer; 2018 Jun; 9(6):707-717. PubMed ID: 29624915
[TBL] [Abstract][Full Text] [Related]
18. Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis.
Sun Y; Liao M; He L; Zhu C
Medicine (Baltimore); 2017 Oct; 96(43):e8367. PubMed ID: 29069026
[TBL] [Abstract][Full Text] [Related]
19. Rationale for Mastectomy after Neoadjuvant Chemotherapy.
Gusic LH; Walsh K; Flippo-Morton T; Sarantou T; Boselli D; White RL
Am Surg; 2018 Jan; 84(1):126-132. PubMed ID: 29428039
[TBL] [Abstract][Full Text] [Related]
20. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
